These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 24116915)

  • 1. Novel therapy based on camelid nanobodies.
    Unciti-Broceta JD; Del Castillo T; Soriano M; Magez S; Garcia-Salcedo JA
    Ther Deliv; 2013 Oct; 4(10):1321-36. PubMed ID: 24116915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Camelid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena.
    Pain C; Dumont J; Dumoulin M
    Biochimie; 2015 Apr; 111():82-106. PubMed ID: 25656912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Camelid nanobodies: killing two birds with one stone.
    Desmyter A; Spinelli S; Roussel A; Cambillau C
    Curr Opin Struct Biol; 2015 Jun; 32():1-8. PubMed ID: 25614146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Camelid immunoglobulins and nanobody technology.
    Muyldermans S; Baral TN; Retamozzo VC; De Baetselier P; De Genst E; Kinne J; Leonhardt H; Magez S; Nguyen VK; Revets H; Rothbauer U; Stijlemans B; Tillib S; Wernery U; Wyns L; Hassanzadeh-Ghassabeh G; Saerens D
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):178-83. PubMed ID: 19026455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobodies: natural single-domain antibodies.
    Muyldermans S
    Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of single domain antibody fragments derived from camelids and generation of manifold constructs.
    Vincke C; Gutiérrez C; Wernery U; Devoogdt N; Hassanzadeh-Ghassabeh G; Muyldermans S
    Methods Mol Biol; 2012; 907():145-76. PubMed ID: 22907350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanobodies and their potential applications.
    Hassanzadeh-Ghassabeh G; Devoogdt N; De Pauw P; Vincke C; Muyldermans S
    Nanomedicine (Lond); 2013 Jun; 8(6):1013-26. PubMed ID: 23730699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Camelid Single-Domain Antibodies for the Development of Potent Diagnosis Platforms.
    Brilhante-da-Silva N; de Oliveira Sousa RM; Arruda A; Dos Santos EL; Marinho ACM; Stabeli RG; Fernandes CFC; Pereira SDS
    Mol Diagn Ther; 2021 Jul; 25(4):439-456. PubMed ID: 34146333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small nanobody drugs win big backing from pharma.
    Williams SC
    Nat Med; 2013 Nov; 19(11):1355-6. PubMed ID: 24202374
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
    Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
    Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging.
    Massa S; Xavier C; De Vos J; Caveliers V; Lahoutte T; Muyldermans S; Devoogdt N
    Bioconjug Chem; 2014 May; 25(5):979-88. PubMed ID: 24815083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single domain antibodies from camelids in the treatment of microbial infections.
    De Greve H; Fioravanti A
    Front Immunol; 2024; 15():1334829. PubMed ID: 38827746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel promiscuous class of camelid single-domain antibody contributes to the antigen-binding repertoire.
    Deschacht N; De Groeve K; Vincke C; Raes G; De Baetselier P; Muyldermans S
    J Immunol; 2010 May; 184(10):5696-704. PubMed ID: 20404276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in the study of natural small molecular antibody].
    Zhu L; Zhang DP
    Yao Xue Xue Bao; 2012 Oct; 47(10):1281-6. PubMed ID: 23289139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation, expression and utilization of single-domain antibodies for in vivo protein localization and manipulation in sea urchin embryos.
    Schrankel CS; Gökirmak T; Lee CW; Chang G; Hamdoun A
    Methods Cell Biol; 2019; 151():353-376. PubMed ID: 30948018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of nanobodies for therapeutic applications.
    Van Bockstaele F; Holz JB; Revets H
    Curr Opin Investig Drugs; 2009 Nov; 10(11):1212-24. PubMed ID: 19876789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A camelid antibody candidate for development of a therapeutic agent against Hemiscorpius lepturus envenomation.
    Yardehnavi N; Behdani M; Bagheri KP; Mahmoodzadeh A; Khanahmad H; Shahbazzadeh D; Habibi-Anbouhi M; Hassanzadeh Ghassabeh G; Muyldermans S
    FASEB J; 2014 Sep; 28(9):4004-14. PubMed ID: 24891523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody repertoire development in camelids.
    De Genst E; Saerens D; Muyldermans S; Conrath K
    Dev Comp Immunol; 2006; 30(1-2):187-98. PubMed ID: 16051357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotoxins and nanobody-based immunotoxins: review and update.
    Khirehgesh MR; Sharifi J; Safari F; Akbari B
    J Drug Target; 2021 Sep; 29(8):848-862. PubMed ID: 33615933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.